In the primary analysis, GLP-1 RA use was associated with a 44% lower odds of PUD diagnosis compared with non-use (adjusted Odds Ratio [aOR]: 0.56
Bagsvaerd, Denmark: Novo Nordisk
If the process feels opaque or clunky, assume other core functions may be similarly neglected
Understanding how GLP-1 medications affect inflammation more broadly helps frame why medications developed for metabolic conditions are showing up as potentially beneficial across a range of inflammatory diseases including eczema, psoriasis, and rheumatoid arthritis
Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy
At the same time, it can be used as the substrate of GST to participate in the two-phase detoxification in plants, to effectively alleviate the stress of toxic xenobiotics (Geu-Flores et al., 2011)